Profil
Jun Du is currently the Chief Executive Officer at Prinston Pharmaceutical, Inc. Prior to this, he served as the Vice Chairman at Zhejiang Huahai Pharmaceutical Co., Ltd.
from 2019 to 2022.
Postes actifs de Jun Du
Sociétés | Poste | Début |
---|---|---|
Prinston Pharmaceutical, Inc.
Prinston Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Prinston Pharmaceutical, Inc. develops, manufactures, markets, and sells generic prescription products. Its products include Benazepril, Donepezil, Escitalopram, Irbesartan, and Lamotrigine. The company was founded by Hai Wang in March 2005 and is headquartered in Cranbury, NJ. | Directeur Général | - |
Anciens postes connus de Jun Du
Sociétés | Poste | Fin |
---|---|---|
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. | Directeur/Membre du Conseil | 17/05/2022 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
Prinston Pharmaceutical, Inc.
Prinston Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Prinston Pharmaceutical, Inc. develops, manufactures, markets, and sells generic prescription products. Its products include Benazepril, Donepezil, Escitalopram, Irbesartan, and Lamotrigine. The company was founded by Hai Wang in March 2005 and is headquartered in Cranbury, NJ. | Health Technology |